-- select article --
CYSTADENOMA - Biliary Cystic Neoplasm: Biliary Cystadenoma and Biliary Cystadenocarcinoma
DIAGNOSIS PLD - Liver Involvement in Autosomal-Dominant Polycystic Kidney Disease: Therapeutic Dilemma
DIAGNOSIS PLD - Clinical Profile of Autosomal Dominant Polycystic Liver Disease
DIAGNOSIS PLD - Multiple cysts in the liver autosomal dominant polycystic liver disease. Netherlands
DIAGNOSIS PLD - ADPLD liver disease in a family without PKD China
DEROOFING - Percutaneous aspiration of hepatic cysts does not provide definitive therapy
DEROOFING - Use of Cyanoacrylate Glue for Sclerosis of a Recurrent Symptomatic Hepatic Cyst
DEROOFING - Long-term results of laparoscopic fenestration for patients with congenital liver cysts
DEROOFING - Laparoscopic palliation of polycystic liver disease.
DEROOFING - Surgical strategy for cystic diseases of the liver in a western hepatobiliary center.
DEROOFING - Laparoscopic deroofing of hepatic cyst
DEROOFING - Laparoscopic Fenestration of a Simple Hepatic Cyst
DEROOFING - Laparoscopic treatment of non parasitic hepatic cysts.
DEROOFING - Laparoscopic liver surgery
DEROOFING - Laparoscopic fenestration for the treatment of patients with severe adult polycystic liver disease.
DEROOFING - Single non-parasitic liver cyst
DEROOFING - Surgical treatment of primary liver cysts. Personal experience
DEROOFING - Laparoscopic cyst decortication in autosomal dominant polycystic kidney disease: impact on pain, hypertension, and renal function
DEROOFING - Laparoscopic Fenestration of a simple hepatic cyst
DEROOFING - Results of percutaneous sclerotherapy and surgical treatment in patients with symptomatic simple liver cysts and polycystic liver disease
DEROOFING - Laparoscopic cyst decortication impact on pain hypertension renal function
DEROOFING - Successful aspiration and ethanol sclerosis of a large, symptomatic, simple liver cyst:
DEROOFING - Serial Ethanol Ablation of Multiple Hepatic Cysts as an Alternative to Liver Transplantation
DEROOFING - Dr. Valente Minimally Invasive Surgical Applications in Polycystic Kidney Disease
DEROOFING - Mini invasive approach to the treatment of liver cysts
DEROOFING - Radiologic Management of Cysts in the Abdomen and Pelvis
DEROOFING vs resection - Hepatic Cysts 1999
DEROOFING vs resection - Tailoring the management of non parasitic liver cysts
DEROOFING vs resection - Surgical strategy for cystic diseases of the liver in a western hepatobiliary center.
DR. DRENTH Lanreotide
DR. DRENTH Lanreotide reduces liver
DR. DRENTH Somatostatin reduce liver PLD.
DR. DRENTH Cysts ADPLD
DR. DRENTH PLD critical Rx appraisal
DR. DRENTH Lanreotide PLD Clinical Trial
DR. DRENTH Bio
DR. HARRIS Bio
DR. HOGAN Somatostatin clinical trial
DR. HOGAN Bio
DR. HOGAN Slides PLD Lecture
DR. HOGAN PLD Webinar
DR. HOGAN PLD
DR. MASYUK Randomized octreotide clinical trial
DR. MASYUK Role of cilia regulating bilel
DR. MASYUK Octreotide animal study
DR. MASYUK Animal model for ARPKD
DR. MASYUK Hepatic artery portal Vein remodeling
DR. MASYUK Hepatic artery in rat liver
DR. MASYUK Animal model ARPKD
DR. MASYUK Cholangiocyte cells in rat liver
DR. MASYUK Octreotide inhibits cholangiocytes
DR. MASYUK Isolation cholangiocyte primary cilia
DR. MASYUK Octreotide Inhibits PLD
DR. NAGORNEY biography
DR. NAGORNEY Polycystic Liver Disease 2009
DR. NAGORNEY Synopsis of Liver Resection
DR. NAGORNEY Adult Polycystic Liver Disease 1997
DR. NAGORNEY Living Liver Donation vs Hepatectomy
DR. NAGORNEY elective Management HVOO 1997
DR. NAGORNEY Liver resection 1995
DR. NAGORNEY Highly Symptomatic PLD
DR. NAGORNEY Inferior Vena Cava Stenting PLD
DR. NAGORNEY Surgical Management PLD 2007
DR. NAGORNEY One Size Does Not Fit All
DR. SOMLO 5 genes PKD PLD
DR. SOMLO PLD cholangiocyte signalling
DR. SOMLO PLD Treatment severe PLD
DR. SOMLO Novel mutations in PLD
DR. TORRES PLD lecture listen
DR. TORRES Biography
DR. TORRES PLD Treatment severe PLD
DR. TORRES Liver cysts PCK rat resembles PLD
DR. TORRES Liver cysts MRI measures cyst volume
DR. TORRES CRISP Renal structure
DR. TORRES CRISP Volume Progression
DR. TORRES CRISP MRI study
DR. TORRES CRISP cyst number PKD1 or PKD2
DR. TORRES CRISP Renal Perfusion
DR. TORRES PLD symptoms
DR. TORRES PLD Pain
DR. TORRES One Size Does Not Fit All Rx PLD
DR. TORRES Unruptured intracranial aneurysms
TDR. TORRES olvaptan kidney vol 3.1%:cyst vol 1.6%
DR. TORRES Blood pressure ADPKD non-dipping
DR. TORRES TEMPO design ADPKD
DR. TORRES Modifiable factors ADPKD
DR. TORRES DKK3 severity ADPKD
DR. TORRES Playing with Evolution
DR. TORRES Octreotide randomized trial
DR. TORRES Medical surgical Rx PLD
DR. TORRES articles
DR. TORRES more articles
DR. UBARA Transcatheter hepatic artery embolization
DR. UBARA intravascular embolization in PLD
DR. UBARA Transcatheter Arterial Embolization PLD
DR. UBARA Transcatheter Arterial Embolization Therapy
DR. UBARA Intravascular embolization therapy PLD
DR. UBARA Multiple cysts in ADPLD
HOT FLASHES - Effexor for hot flashes
HOT FLASHES - escitalopram (Lexapro) mod helps
HOT FLASHES - MPA increases breast cancer
HOT FLASHES - Breast cancer decliines
HOT FLASHES - Black cohosh no help hot flashes
HOT FLASHES - Flax no help for hot flashes
HOT FLASHES - Soy no help hot flash
HOT FLASHES - keishi-bukuryo-gan no help hot flash
HOT FLASHES - dong quai no help hot flashes
HOT FLASHES - venlafaxine (Effexor)
LIVER RESECTION NAGORNEY Mayo 2009
LIVER RESECTION NAGORNEY HVOO
LIVER RESECTION NAGORNEY - Bio of Dr. Nagorney
LIVER RESECTION NAGORNEY Mayo 1995
LIVER RESECTION NAGORNEY -Mayo 1990
LIVER RESECTION NAGORNEY - Inferior Vena Cava Stenting PLD
LIVER RESECTION TORRES PLD
LIVER RESECTION TORRES One Size Does Not Fit All
LIVER RESECTION TORRES liver cyst infection1990
LIVER RESECTION Surgical management PLD Jenkins
LIVER RESECTION PLD
LIVER RESECTION classification PLD
LIVER RESECTION China 2004
LIVER RESECTION vs Fenestration
LIVER CYST RECEPTORS Octreotide blocks all 3
LIVER CYST RECEPTORS Liver cysts have hormone receptors
LIVER TRANSPLANT Right Hepatectomy for Living Liver Donation vs Right Hepatectomy for Disease
LIVER TRANSPLANT - Multimodality Imaging for Complications and Transplant Evaluation
OCTREOTIDE DIET - Small mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation
OCTREOTIDE DIET - Follicle-stimulating hormone increases cholangiocyte proliferation
OCTREOTIDE PAGE - More on Octreotide, a clinical trial.
OCTREOTIDE PAGE - How Octreotide Works
OCTREOTIDE PAGE - Some Symptoms From Octreotide
OCTREOTIDE PAGE - How Octreotide Works
OCTREOTIDE PAGE - Octreotide articles of its use in Acromegaly
OCTREOTIDE PAGE - Somatostatin Prescribing Information
OCTREOTIDE - Electron Microscope:Liver cysts have hormone receptors, growth hormone receptors, insulin like receptors Octreotide blocks all 3
OCTREOTIDE - Electron Microscope:abstract of the article
OCTREOTIDE - Clinical Trial Mayo sandostatin LAR IM 28 days USA
OCTREOTIDE - Clinical Trial Netherlands Belgium Lanreotide
OCTREOTIDE - Clinical Trial Italy somatostatin
OCTREOTIDE - Somatostatin Italian study reduces kidney cysts: safety and efficacy of somatostatin in ADPKD.
OCTREOTIDE - prescribing info
OCTREOTIDE - more prescribing info
OCTREOTIDE - how to prepare
OCTREOTIDE - octreotide somatostatin analogue
OCTREOTIDE - from wikipedia
OCTREOTIDE - TORRES - Octreotide Inhibits Hepatic Cystogenesis in PLD Rodent by Reducing Cholangiocyte Adenosine
OCTREOTIDE - Somatostatin analogues reduce liver volume in polycystic liver disease
OCTREOTIDE - Uses: Dr. Grantham on octreotide
OCTREOTIDE - Uses: Dr. Hogan on PLD octreotide
OCTREOTIDE - Uses: octreotide obesity
OCTREOTIDE - Uses: ascites octreotide and TPN
OCTREOTIDE - Uses: breast cancer
OCTREOTIDE - Uses: long term treatment with somatostatin analogue for endocrine tumor 18 years
OCTREOTIDE - Uses: octreotide reduces portal pressure
OCTREOTIDE - Uses: octreotide acromegaly
OCTREOTIDE - clinical trial octreotide implant for acromegaly
OCTREOTIDE - Lanreotide: Clinical trial Netherlands and Belgium with lanreotide clinical trial subcutaneous 28 days
OCTREOTIDE - Works by imitating the action of somatostatin- sandostatin LAR
OCTREOTIDE - Lanreotide crossover study with octreotide long-acting
OCTREOTIDE - Lanreotide Autogel
OCTREOTIDE - vapreotide
PLD Diet Liver book
PLD DIET Small mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation
PLD DIET Follicle-stimulating hormone increases cholangiocyte proliferation
PLD TREATMENT - One size does not fit all PLD
PLD TREATMENT - Lv resection fenestration China 7 patients
PLD TREATMENT - Lv resection China new classification
PLD TREATMENT - China PLDw/o PKD
PLD TREATMENT - Clinical Profile of ADPLD
PLD TREATMENT - Lv Tx a relevant treatment for PLD
PLD TREATMENT - Lv Tx PLD
PLD TREATMENT - TAE
PLD TREATMENT - Liver involevement ADPKD
PLD TREATMENT - Miniinvasive treatment PLD
PLD TREATMENT - Alberta
PLD TREATMENT - Mayo 2009
PLD TREATMENT - rad Tx Evaluation
PLD TREATMENT - imaging complications for tx evaluation abstract
PLD TREATMENT - Rad Management Cysts Abd
PLD TREATMENT - Somatostatin in ADPKD Italy
PLD TREATMENT - Hogan MD
PLD TREATMENT - Octreotide Rx pulldown menu
PLD TREATMENT - Octreotide inhibits PLD in rodent model
PLD TREATMENT - Ethanol Ablation alt to Lv Tx
PLD TREATMENT - ADPLD Netherlands
PLD TREATMENT - Perrone
PLD TREATMENT - TAE in PLD Ubara Japan
PLD TREATMENT - Somatostatin decreases liver cyst volume Drenth
PLD TREATMENT - Soy influenced by gender
PLD TREATMENT - Ascites helped somatostatin
PLD TREATMENT - Milk thistle
PLD TREATMENT - Sclerotherapy PLD
PLD TREATMENT - Maca avoid PLD increases hormones
SIROLIMUS: FDA Alert
SIROLIMUS: FDA Warns of Increased Mortality Risk with Sirolimus in Liver Transplants
SIROLIMUS: FDA: Increased Mortality in Stable Liver Transplant Recipients Taking Sirolimus
SIROLIMUS: This Trial for Liver Patients no longer recruiting
SIROLIMUS: This Trial for Liver Patients no longer recruiting
SIROLIMUS PAGE: FDA alert about liver transplants and avoiding sirolimus
SIROLIMUS: Relationship between renal resistance index and renal function in liver transplant recipients after cessation of calcineurin inhibitor.
SIROLIMUS: Acute liver transplant rejection upon immunosuppression withdrawal in a tolerance induction trial:
SIROLIMUS: Associated Hepatotoxicity in Liver Transplantation
SIROLIMUS: Reduces Polycystic Liver Volume in ADPKD Patients
SIROLIMUS: Reduces Polycystic Liver Volume in ADPKD Patients; the abstract
SIROLIMUS: ameliorates the enhanced expression of metalloproteinases in a rat model of autosomal dominant polycystic kidney disease.
SIROLIMUS: New therapeutic prospects in autosomal dominant polycystic kidney disease
SIROLIMUS: Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD)
TAE - Percutaneous transcatheter hepatic artery embolization for liver cysts
TAE - Effects of intravascular embolization therapy in PLD
TAE - Transcatheter Arterial Embolization Therapy for a Massive Polycystic Liver
TAE - Transcatheter Arterial Embolization Therapy
TAE - Intravascular embolization therapy in a patient with an enlarged polycystic liver.
TAE - Multiple cysts in the liver autosomal dominant polycystic liver disease